The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Cangzhou People's Hospital, Cangzhou, China.
Front Endocrinol (Lausanne). 2022 Feb 14;13:792159. doi: 10.3389/fendo.2022.792159. eCollection 2022.
Previous studies showed that age is the most important factor that determines the outcome after embryo transfer (ET), with either fertilization (IVF) or intracytoplasmic sperm injection (ICSI), regardless whether fresh or frozen cycles. The average cumulative live birth rate (CLBR) following a single ovarian stimulation cycle in women of advanced reproductive age (≥38 years of age) has been reported to be 22.6-34.1%. The purpose of this study is to compare the CLBR after a single ovarian stimulation cycle in women of different advanced reproductive age bracket (38/39, 40/41, 42/43 years of age or older), and to explore the factors (e.g., age, type of infertility, body mass index (BMI), ovarian stimulation protocols) associated with CLBR.
This retrospective analysis included all women of advanced reproductive age (38 years or older) undergoing IVF or ICSI at authors' institute during a period from January 1, 2016 to December 31, 2018. The study protocol was approved by the Ethics Committee of the Second Hospital of Hebei Medical University (No. 2021-P045). Subjects with underlying diseases were excluded from analysis. The last follow-up was conducted in December 2020, with minimal 2-year follow-up.
The final analysis included 826 women (40.00 ± 2.10 years of age at the time of ovarian stimulation; n = 633 and 193 for IVF-ET and ICSI-ET, respectively). The number of women in each age bracket was: 424 for 38/39 y, 226 for 40/41 y, 118 for 42/43 y, and 58 for ≥44 y. The number of transferable embryos was 2 (interquartile range: 2,4) for 38/39 y, 2 (2,3) for 40/41 y, 2 (2,3) for 42/43 y, and 2 (1.75,3) for ≥44 y. The rate of fresh embryo transfer was comparable (62.03-72.58%) among the 4 age brackets. The average CLBR following a single cycle was 26.27% in the overall study population, 32.31% for 38/39 y, 26.99% for 40/41 y, 14.4% for 42/43 y, and 3.44% for ≥44 y (0.001). In multivariate regression, CLBR was independently associated with younger age (OR for each year: 1.538, 95%CI: 1.193, 1.984) and higher number of transferable embryos (OR for each embryo: 1.495, 95%CI: 1.297, 1.722). CLBR differed significantly in the 38/39 group ( = 0.014), with higher rate in women receiving the Gonadotropin-releasing hormone agonist (GnRH-a) long or GnRH-a ultra-long protocols.
Forty-two years of age seemed to be a critical cutoff to achieve reasonable level of CLBR after a single ovarian stimulation cycle in women of advanced reproductive age.
既往研究表明,年龄是决定胚胎移植(ET)后结局的最重要因素,无论新鲜周期还是冷冻周期,受精(IVF)或卵胞浆内单精子注射(ICSI)均如此。在高龄(≥38 岁)女性中,单次卵巢刺激周期后的累积活产率(CLBR)平均为 22.6%-34.1%。本研究旨在比较不同高龄亚组(38/39 岁、40/41 岁、42/43 岁及以上)女性单次卵巢刺激周期后的 CLBR,并探讨与 CLBR 相关的因素(如年龄、不孕类型、体质量指数(BMI)、卵巢刺激方案)。
本回顾性分析纳入了 2016 年 1 月 1 日至 2018 年 12 月 31 日在作者所在机构接受 IVF 或 ICSI 的所有高龄(≥38 岁)女性。该研究方案获得了河北医科大学第二医院伦理委员会的批准(编号:2021-P045)。排除患有基础疾病的患者。末次随访时间为 2020 年 12 月,最小随访时间为 2 年。
最终分析纳入 826 名女性(卵巢刺激时年龄为 40.00±2.10 岁;分别有 633 名和 193 名接受 IVF-ET 和 ICSI-ET)。各年龄亚组的女性数量如下:38/39 岁组 424 名、40/41 岁组 226 名、42/43 岁组 118 名、≥44 岁组 58 名。38/39 岁组可移植胚胎数为 2(四分位距:2,4)、40/41 岁组为 2(2,3)、42/43 岁组为 2(2,3)、≥44 岁组为 2(1.75,3)。4 个年龄亚组的新鲜胚胎移植率相当(62.03%-72.58%)。总体研究人群单次周期后的平均 CLBR 为 26.27%,38/39 岁组为 32.31%、40/41 岁组为 26.99%、42/43 岁组为 14.4%、≥44 岁组为 3.44%(0.001)。多变量回归显示,CLBR 与年龄较小(每年的 OR:1.538,95%CI:1.193,1.984)和可移植胚胎数较多(每个胚胎的 OR:1.495,95%CI:1.297,1.722)独立相关。38/39 岁组的 CLBR 差异有统计学意义( = 0.014),接受促性腺激素释放激素激动剂(GnRH-a)长方案或 GnRH-a 超长方案的女性 CLBR 更高。
42 岁似乎是高龄女性单次卵巢刺激周期后实现合理 CLBR 的临界值。